Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Han Lee

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in Renal Cell CarcinomaChung-Han Lee, Robert J Motzer
Urologic Oncology|December 4, 2014
Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinomaChung-Han Lee, Robert J Motzer
Nature Reviews. Nephrology|January 20, 2017
Kidney cancer in 2016: The evolution of anti-angiogenic therapy for kidney cancerChung-Han Lee, Robert J Motzer
Therapeutic Advances in Medical Oncology|September 16, 2021
New approaches to first-line treatment of advanced renal cell carcinomaDaniel J George, Chung-Han Lee, Daniel Heng
Annual Review of Pharmacology and Toxicology|September 14, 2006
mTOR pathway as a target in tissue hypertrophyChung-Han Lee, Ken Inoki, Kun-Liang Guan
International Journal of Environmental Research and Public Health|January 20, 2021
Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut MicrobiomeShih-Chen Fu, Chung-Han Lee, Hsiuying Wang
Cancer Treatment Reviews|January 9, 2014
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinomaTomohiro Funakoshi, Chung-Han Lee, James J Hsieh
Current Opinion in Urology|July 27, 2019
The current role for adjuvant and neoadjuvant therapy in renal cell cancerJack P Gleeson, Robert J Motzer, Chung-Han Lee
Nature Reviews. Urology|November 12, 2022
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascadeKelly N Fitzgerald, Robert J Motzer, Chung-Han Lee
Trends in Immunology|May 13, 2018
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be DifferentChung-Han Lee, Roman Yelensky, Karin Jooss, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in Renal Cell CarcinomaChung-Han Lee, Robert J Motzer
Urologic Oncology|December 4, 2014
Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinomaChung-Han Lee, Robert J Motzer
Nature Reviews. Nephrology|January 20, 2017
Kidney cancer in 2016: The evolution of anti-angiogenic therapy for kidney cancerChung-Han Lee, Robert J Motzer
Therapeutic Advances in Medical Oncology|September 16, 2021
New approaches to first-line treatment of advanced renal cell carcinomaDaniel J George, Chung-Han Lee, Daniel Heng
Annual Review of Pharmacology and Toxicology|September 14, 2006
mTOR pathway as a target in tissue hypertrophyChung-Han Lee, Ken Inoki, Kun-Liang Guan
International Journal of Environmental Research and Public Health|January 20, 2021
Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut MicrobiomeShih-Chen Fu, Chung-Han Lee, Hsiuying Wang
Cancer Treatment Reviews|January 9, 2014
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinomaTomohiro Funakoshi, Chung-Han Lee, James J Hsieh
Current Opinion in Urology|July 27, 2019
The current role for adjuvant and neoadjuvant therapy in renal cell cancerJack P Gleeson, Robert J Motzer, Chung-Han Lee
Nature Reviews. Urology|November 12, 2022
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascadeKelly N Fitzgerald, Robert J Motzer, Chung-Han Lee
Trends in Immunology|May 13, 2018
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be DifferentChung-Han Lee, Roman Yelensky, Karin Jooss, et al.
Pageof 11